Gremubamab, previously known as this molecule, represents a promising therapeutic avenue targeting the biomarker in certain hematologic conditions . The drug functions as an antibody – specifically, a https://gremubamab149387.mpeblog.com/76330884/gremubamab-a-deep-exploration-into-the-compound-s-promise